Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Haen

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Oncotarget|February 18, 2016
Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumabSebastian P Haen, Benjamin J Schmiedel, Kathrin Rothfelder, et al.
Oncoimmunology|January 9, 2018
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cellsStefanie Maurer, Korbinian Nepomuk Kropp, Gerd Klein, et al.
Biomarkers in Medicine|December 18, 2020
Integrative public data-mining pipeline for the validation of novel independent prognostic biomarkers for lung adenocarcinomaSusanne Ghandili, Tim Oqueka, Melanie Schmitz, et al.
Bone Marrow Transplantation|May 16, 2019
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantationL Axt, A Naumann, J Toennies, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|January 28, 2019
Facial surgery for cosmetic purposes: Practice guidelinesL Guyot, F Saint-Pierre, V Bellot-Samson, et al.
Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2017
Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignanciesSebastian P Haen, Vicky Eyb, Nora Mirza, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interactionNora Mirza, Manfred Zierhut, Andreas Korn, et al.
Annals of Surgical Oncology|February 5, 2017
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment ProtocolsMarkus W Löffler, Heiko Schuster, Anne Zeck, et al.
Leukemia|July 21, 2016
An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemiaS P Koerner, M C André, J S Leibold, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Oncotarget|February 18, 2016
Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumabSebastian P Haen, Benjamin J Schmiedel, Kathrin Rothfelder, et al.
Oncoimmunology|January 9, 2018
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cellsStefanie Maurer, Korbinian Nepomuk Kropp, Gerd Klein, et al.
Biomarkers in Medicine|December 18, 2020
Integrative public data-mining pipeline for the validation of novel independent prognostic biomarkers for lung adenocarcinomaSusanne Ghandili, Tim Oqueka, Melanie Schmitz, et al.
Bone Marrow Transplantation|May 16, 2019
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantationL Axt, A Naumann, J Toennies, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|January 28, 2019
Facial surgery for cosmetic purposes: Practice guidelinesL Guyot, F Saint-Pierre, V Bellot-Samson, et al.
Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2017
Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignanciesSebastian P Haen, Vicky Eyb, Nora Mirza, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interactionNora Mirza, Manfred Zierhut, Andreas Korn, et al.
Annals of Surgical Oncology|February 5, 2017
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment ProtocolsMarkus W Löffler, Heiko Schuster, Anne Zeck, et al.
Leukemia|July 21, 2016
An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemiaS P Koerner, M C André, J S Leibold, et al.
Pageof 5